University of Liverpool spin-out, AI-Sight, funding and collaboration success
University of Liverpool AI diagnostic technology spin-out, AI-Sight, has successfully concluded its seven-figure equity funding round from experienced healthcare industry figures and investors.
The funders, committed to developing innovation and business in the North West of England, include Sir Michael Bibby (Chairman of the Bibby Line Group and Hon PhD, University of Liverpool), Phil Kirby (former Managing Director of InHealth Intelligence), Pitalia Capital (the family office of Anil Pitalia, Founder of SpaMedica) and Deepbridge Capital.
This follows the Class 1 medical device certification of AI-Sight’s first commercial product. The AI software device is designed to support training and diagnostic decision-making by human graders of diabetic retinopathy in retinal scans.
Building on this success, AI-Sight has signed a research collaboration agreement with the UK’s largest specialist provider of diagnostic and healthcare solutions, the InHealth Group. InHealth has been working closely with the NHS for over thirty years.
